COLUMBUS, Ohio, May 21, 2012 /PRNewswire/ -- On Monday, May 21, 2012 the final beam will be lifted into place at the new James Cancer Hospital and Solove Research Institute

New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs.

A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer.

A new study has identified a gene mutation that researchers estimate dates back to 11,600 B.C., making it the second oldest human disease mutation yet discovered.

Peloton’s Success is in Response to Stefanie Spielman’s Challenge to “Continue to Fight” Columbus, Ohio (PRWEB) November 12, 2011 Stefanie's